Midatech Pharma US Inc. 4

Accession 0001354488-15-005395

CIK 0000919745operating

View on SEC.gov Company Profile

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 7:56 AM ET

Size

33.7 KB

Accession

0001354488-15-005395

Insider Transaction Report

Form 4

Period: 2015-12-04

Midatech Pharma US Inc.DARA

Lieberman Gail

Director

Transactions

Disposition to Issuer
Common Stock
2015-12-04−41→ 0 total
Disposition to Issuer
Stock Option
2015-12-04−375→ 0 total
Exercise: $36.00From: 2012-03-23Exp: 2020-03-23→ Common Stock (375 underlying)
Disposition to Issuer
Stock Option
2015-12-04−1,000→ 0 total
Exercise: $15.15From: 2011-08-02Exp: 2021-04-01→ Common Stock (1,000 underlying)
Disposition to Issuer
Stock Option
2015-12-04−625→ 0 total(indirect: By LLC)
Exercise: $34.40From: 2012-05-20Exp: 2019-05-06→ Common Stock (625 underlying)
Disposition to Issuer
Stock Option
2015-12-04−2,000→ 0 total
Exercise: $10.25From: 2012-09-15Exp: 2021-09-15→ Common Stock (2,000 underlying)
Disposition to Issuer
Stock Option
2015-12-04−12,000→ 0 total
Exercise: $6.55From: 2011-12-27Exp: 2021-12-27→ Common Stock (12,000 underlying)
Disposition to Issuer
Stock Option
2015-12-04−10,000→ 0 total
Exercise: $5.00From: 2015-12-04Exp: 2022-05-15→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Option
2015-12-04−12,000→ 0 total
Exercise: $3.75From: 2014-05-10Exp: 2023-05-10→ Common Stock (12,000 underlying)
Disposition to Issuer
Stock Option
2015-12-04−38,462→ 0 total
Exercise: $1.17From: 2015-05-19Exp: 2024-05-19→ Common Stock (38,462 underlying)
Disposition to Issuer
Stock Option
2015-12-04−32,000→ 0 total
Exercise: $0.79From: 2015-02-09Exp: 2025-02-09→ Common Stock (32,000 underlying)
Disposition to Issuer
Stock Option
2015-12-04−21,739→ 0 total
Exercise: $0.69From: 2015-09-19Exp: 2025-05-19→ Common Stock (21,739 underlying)
Disposition to Issuer
Stock Option
2015-12-04−10,901→ 0 total
Exercise: $0.86From: 2015-11-15Exp: 2025-09-01→ default (10,901 underlying)
Disposition to Issuer
Preferred Stock
2015-12-04−10→ 0 total
Exercise: $0.00From: 2014-06-04→ Common Stock (9,009 underlying)
Disposition to Issuer
Warrants
2015-12-04−9,009→ 0 total
Exercise: $1.67From: 2014-06-04Exp: 2019-06-04→ Common Stock (9,009 underlying)

Footnotes (5)

[F1]Common stock disposed of pursuant to the Agreement and Plan of Merger among DARA BioSciences, Inc. (DARA) and Midatech Pharma PLC (Midatech) and certain other parties thereto, whereby each share of common stock of DARA was converted into (i) 0.136 American Depository Receipts (Midatech ADRs), with each Midatech ADR representing two Midatech ordinary shares, plus (ii) one contingent value right representing the right to receive contingent payments if specified milestones are achieved within agreed time periods, plus (iii) cash in lieu of fractional Midatech ADRs. The closing price of the Midatech ordinary shares on December 4, 2015, the effective date of the merger was ?2.65.
[F2]These options were assumed by Midatech in connection with the Merger and replaced with options to purchase 0.136 Midatech ADRs for each DARA option held, at an exercise price equal to the exercise price of the applicable DARA option divided by 0.136.
[F3]These warrants were assumed by Midatech in connection with the Merger and replaced with warrants to purchase 0.136 Midatech ADRs for each warrant held at an exercise price equivalent to the exercise price of a DARA option divided by 0.136.
[F4]These preferred shares have no expiration date.
[F5]These preferred shares were purchased by Midatech pursuant to the merger agreement for $1,000 per share for total consideration of $10,000.

Documents

1 file

4
issuerdirect_section16.xmlPrimary
PRIMARY DOCUMENT

Issuer

Midatech Pharma US Inc.

CIK 0000919745

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000919745

Filing Metadata

Form type: 4
Filed: Dec 6, 7:00 PM ET
Accepted: Dec 7, 7:56 AM ET
Size: 33.7 KB

View on SEC.gov